Quarterly Results

  • Company Name :
Astrazeneca Pharma India Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 506820
  • NSE Symbol:
  • ASTRAZEN
  • P/E(TTM):
  • 106.27
  • ISIN Demat:
  • INE203A01020
  • Div & Yield%:
  • 0.36
  • EPS(TTM):
  • 83.21
  • Book Value(₹):
  • 319.60
  • Market Cap(₹Cr.):
  • 22,106.50
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 611.57 559.09 526.31
Excise Duty 0.00 0.00 0.00
Net Sales 611.57 559.09 526.31
Other Operating Income 0.00 0.00 0.00
Other Income 6.61 6.17 11.24
Total Income 618.18 565.26 537.55
Total Expenditure 566.74 489.20 445.56
PBIDT 51.44 76.06 91.99
Interest 1.06 0.67 0.72
PBDT 50.38 75.39 91.27
Depreciation 3.84 2.57 16.57
Tax 4.00 19.01 22.10
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 9.95 -0.41 -3.23
Reported Profit After Tax 32.59 54.22 55.83
Extra-ordinary Items 1.04 -3.91 -0.25
Adjusted Profit After Extra-ordinary item 31.55 58.13 56.08
EPS (Unit Curr.) 13.04 21.69 22.33
EPS (Adj) (Unit Curr.) 13.04 21.69 22.33
Calculated EPS (Unit Curr.) 13.04 21.69 22.33
Calculated EPS (Adj) (Unit Curr.) 13.04 21.69 22.33
Calculated EPS (Ann.) (Unit Curr.) 52.14 86.75 89.33
Calculated EPS (Adj) (Ann.) (Unit Curr.) 52.14 86.75 89.33
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 5.00 5.00 5.00
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 8.41 13.60 17.48
PBDTM(%) 8.24 13.48 17.34
PATM(%) 5.33 9.70 10.61